About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

US Court Rules Against Lupin in Ramipril Patent Case

by Medindia Content Team on July 20, 2006 at 2:15 PM
Font : A-A+

US Court Rules Against Lupin in Ramipril Patent Case

Pharmaceutical company Lupin Ltd today said that a district court in the US has ruled against the company in a patent infringement suit filed by Sanofi-Aventis and King Pharmaceuticals.

The company informed the Bombay Stock Exchange that the US District Court for the Eastern District of Virginia has issued an opinion following the completion of a trial on Sanofi-Aventis US Patent No - 5061722 relating to Altace (Ramipril) drug and found the patent to be valid.

Advertisement

Lupin Managing Director Kamal Sharma said, "It was a very close call for us and we are disappointed that the Court found the patent to be valid, albeit reluctantly, in the judge's own words." The company plans to to appeal this decision to the Federal Circuit, Sharma added.

The court decision followed a suit filed by King Pharmaceuticals and Sanofi-Aventis against Lupin alleging patent infringement on the '5061722' patent.

The trial was completed in June 2006, the company said. Ramipril (Altance) is a drug used for the treatment of high blood pressure.

Lupin's shares dropped 1.92 per cent to close at Rs 867.25 on the BSE.

Source:PTI News
Advertisement
Advertisement
Advertisement

Recommended Reading

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

US Court Rules Against Lupin in Ramipril Patent Case Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests